Evidence hub

Anemia: cell-therapy evidence by therapy class

Across every stem-cell intervention, ClinicalTrials.gov holds 195 registered records for Anemia — 32 recruiting, 14 at Phase 3 or 4, in 15 countries. Snapshot 2026-08-29.

Medical review statusMedically reviewedReviewed by: Stem Plus medical teamReviewed on: 2026-08-29Last evidence update: 2026-08-29Methodology and editorial standards
Clinical review team: Dr Kamelia Milcheva, Hematologist · Dr Vadym Uvarov, Board-Certified Physician · Hepatobiliary Surgeon · Candidate of Medical SciencesEditorial responsibility: StemCellAtlas research teamEducational information only. This page does not provide medical advice, diagnosis or a treatment recommendation.

The condition, and why cells are proposed

Under 'anaemia' the registry mostly holds aplastic anaemia and marrow-failure syndromes, where haematopoietic transplantation is not experimental at all — it is standard care with decades of protocol refinement. Mesenchymal cells appear alongside it as a graft-support and graft-versus-host-disease adjunct, which is a different and much less settled question.

Therapy classes side by side

Therapy classRegisteredRecruitingPhase 3/4Countries
MSC10013
HSCT163261213
exosomes0000
PRP0000

Counts come from separate registry queries per class; a study testing two interventions can appear in more than one row, so rows do not sum to the all-interventions total.

Geography of the research

United States accounts for about 75% of country mentions among sampled studies; 15 countries host at least one site.

CountryStudies with a site there
United States132
China18
France6
South Korea5
Brazil4
United Kingdom4
Russia2
Canada2

The largest registered studies

Sorted by planned enrolment — size is not quality, but a 300-participant trial can answer questions a 12-participant series cannot.

StudyPhaseStatusPlanned nLead sponsorStart
NCT06065852 — National Registry of Rare Kidney Diseasesn/aRecruiting35,000UK Kidney Association2009-11-06
NCT00212407 — New York Blood Center National Cord Blood ProgramEarly Phase 1Terminated4,476New York Blood Center1993-02
NCT07205523 — High-Altitude Hematology Observation-Stem Cell Transplantation (HALO-SCT)n/aRecruiting1,000Yigeng Cao,MD,PhD2023-09-01
NCT00964821 — Flu Vaccine in Preventing Influenza Infection in Healthy Volunteers and in Patients Who Have Undergone Stem Cell Transplantn/aCompleted459City of Hope Medical Center2007-01
NCT00003816 — Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic CancerPhase 2, Phase 3Completed361Roswell Park Cancer Institute1998-10-19
NCT00701844 — Sharing Our Strength: A Research Study for Bone Marrow/Stem Cell Transplant Survivorsn/aCompleted315University of North Carolina, Chapel Hill2007-07

Most recently registered

StudyPhaseStatusPlanned nLead sponsorStart
NCT06940570 — Methadone as an Alternative Treatment for Children Underdoing HSCTn/aSuspendedn/aUniversity of Texas Southwestern Medical Center2028-01-01
NCT07408583 — Prenatal Transplantation for Fetuses With Fanconi Anemian/aNot Yet Recruitingn/aAgnieszka Czechowicz2028-01
NCT07737262 — Prophylactic NAC to Improve Platelet Engraftment After Haploidentical Transplantation in Severe Aplastic Anemia Patientsn/aNot Yet Recruitingn/aPeking University People's Hospital2026-08-01
NCT07712562 — A Phase 1/2 Study to Evaluate the Safety and Efficacy of Dibotatug (DR-01) in Adults With Bone Marrow Failure Syndromesn/aNot Yet Recruitingn/aDren Bio2026-08
NCT07698080 — Dexamethasone, Intravenous Injection of Human Immunoglobulin, and Increased Infusion of Mononuclear Cells to Reduce Donor Specific Antibodies in Haplon/aNot Yet Recruitingn/aHematology department of the 920th hospital2026-07-03

Reading this honestly

Registration counts measure activity, not effect. A study appears here the moment it is registered — before any participant is enrolled, and regardless of whether results are ever posted. For Anemia specifically, the practical question is which registered study — if any — matches the product a provider is offering, and what its outcome measures actually are.

Frequently asked

How many stem-cell trials exist for Anemia?

195 registered records mention a stem-cell intervention for this condition (2026-08-29 snapshot), of which 32 were recruiting.

Which therapy class is furthest along for Anemia?

Ranked by Phase 3/4 records: HSCT (12), MSC (1), exosomes (0), PRP (0).

Does a recruiting trial mean I can be treated?

No. Trials have eligibility criteria, and joining one is not the same as buying a treatment. Paying a clinic for an unproven intervention outside a registered study gives you neither the protections nor the data collection of a trial.

Registry and literature counts retrieved 2026-08-29 (ClinicalTrials.gov API v2; PubMed E-utilities). Registration or publication volume measures research activity, not effectiveness or approval. Educational information — not medical advice; verify product, indication, legal pathway and evidence with an independent qualified physician. Page generated 2026-08-29. See our editorial standards.

Explore all sections · Data & downloads

Download the query data

Download CSV · Download JSON

Query totals are full API matches; status, phase and country counts describe the first up to 400 returned records per query. Query classes overlap and must not be summed as unique trials. Counts are not treatment outcomes. Snapshot: 2026-08-29. Methods and field definitions.